Skip to content

A Study on the Benefits of Early Standardized Management of Chronic Obstructive Pulmonary Disease (COPD) Patients with Three Highs based on Grassroots COPD Screening: A Prospective, Multicenter, Randomized, Interventional Study in the Real World

A Study on the Benefits of Early Standardized Management of Chronic Obstructive Pulmonary Disease (COPD) Patients with Three Highs Based on Grassroots COPD Screening: A Prospective, Multicenter, Randomized, Interventional Study in the Real World

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092664
Enrollment
Unknown
Registered
2024-11-21
Start date
2024-11-29
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Standardized management group :drug and non drug interventions, regular follow-up
observation group:inactive and proactive intervention

Sponsors

Qingdao Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients aged 40 years and above; Newly diagnosed stable COPD patients in grassroots units; Simultaneously coexisting with hypertension, hyperlipidemia, or hyperglycemia, one, two, or three; Patients who can cooperate with grassroots units in chronic disease management; Patients who are willing and able to sign written informed consent.

Exclusion criteria

Exclusion criteria: Patients currently diagnosed with asthma; Patients with chronic obstructive pulmonary disease (COPD) and other major diseases (such as cancer) related to the three highs; Patients who are also participating in other clinical studies;

Design outcomes

Primary

MeasureTime frame
The incidence of moderate to severe Acute exacerbation of chronic obstructive pulmonary disease(AECOPD);

Secondary

MeasureTime frame
The time of the first moderate to severe acute exacerbation;Time of death;

Countries

China

Contacts

Public ContactHan Wei

Qingdao Municipal Hospital

sallyhan1@163.com+86 185 6185 7838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026